Common use of Disclosure Controls Clause in Contracts

Disclosure Controls. The Company maintains disclosure controls and procedures (as such is defined in Rule 13a-15(e) of the Exchange Act Rules) that comply with the requirements of the Exchange Act; such disclosure controls and procedures have been designed to ensure that information required to be disclosed by the Company in reports that it files or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Commission’s rules and forms, including controls and procedures designed to ensure that such information is accumulated and communicated to the Company’s management to allow timely decisions regarding disclosures. The Company has conducted evaluations of the effectiveness of their disclosure controls as required by Rule 13a-15 of the Exchange Act.

Appears in 35 contracts

Sources: Securities Purchase Agreement (Adverum Biotechnologies, Inc.), Securities Purchase Agreement (Adverum Biotechnologies, Inc.), Sales Agreement (TScan Therapeutics, Inc.)

Disclosure Controls. The Company maintains disclosure controls and procedures (as such is defined in Rule 13a-15(e) of the Exchange Act Rules) that comply with the requirements of the Exchange Act; such disclosure controls and procedures have been designed to ensure that information required to be disclosed by the Company in reports that it files or submit submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Commission’s rules and forms, including controls and procedures designed to ensure that such information is accumulated and communicated to the Company’s management to allow timely decisions regarding disclosures. The Company has conducted evaluations of the effectiveness of their its disclosure controls as required by Rule 13a-15 of the Exchange Act.

Appears in 30 contracts

Sources: Sales Agreement (Nautilus Biotechnology, Inc.), Sales Agreement (Nautilus Biotechnology, Inc.), Sales Agreement (Acrivon Therapeutics, Inc.)

Disclosure Controls. The Company maintains disclosure controls and procedures procedures” (as such is defined in Rule 13a-15(e) of the Exchange Act Rules) that comply with the requirements of the Exchange Act; such disclosure controls and procedures have been designed to ensure that information required to be disclosed by the Company in reports that it files or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Commission’s rules and forms, including controls and procedures designed to ensure that such information is accumulated and communicated to the Company’s management to allow timely decisions regarding disclosures. The Company has conducted evaluations of the effectiveness of their disclosure controls as required by Rule 13a-15 of the Exchange Act.

Appears in 23 contracts

Sources: Underwriting Agreement (Silver Pegasus Acquisition Corp.), Underwriting Agreement (Silver Pegasus Acquisition Corp.), Underwriting Agreement (Timber Road Acquisition Corp)

Disclosure Controls. The Company maintains an effective system of “disclosure controls and procedures procedures” (as such is defined in Rule 13a-15(e) of the Exchange Act RulesAct) that comply complies with the requirements of the Exchange Act; such disclosure controls Act and procedures have that has been designed to ensure that information required to be disclosed by the Company in reports that it files or submit submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Commission’s rules and forms, including controls and procedures designed to ensure that such information is accumulated and communicated to the Company’s management as appropriate to allow timely decisions regarding disclosuresrequired disclosure. The Company has conducted carried out evaluations of the effectiveness of their disclosure controls and procedures as required by Rule 13a-15 of the Exchange Act.

Appears in 23 contracts

Sources: Underwriting Agreement (Precigen, Inc.), Securities Purchase Agreement (Poseida Therapeutics, Inc.), Underwriting Agreement (Nektar Therapeutics)

Disclosure Controls. The Company maintains an effective system of “disclosure controls and procedures procedures” (as such is defined in Rule 13a-15(e) of the Exchange Act RulesAct) that comply complies with the requirements of the Exchange Act; such disclosure controls Act and procedures have that has been designed to ensure that information required to be disclosed by the Company in reports that it files or submit submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Commission’s rules and forms, including controls and procedures designed to ensure that such information is accumulated and communicated to the Company’s management as appropriate to allow timely decisions regarding disclosuresrequired disclosure. The Company has conducted evaluations carried out an evaluation of the effectiveness of their its disclosure controls and procedures as required by Rule 13a-15 of the Exchange Act.

Appears in 22 contracts

Sources: Underwriting Agreement (Sixth Street Specialty Lending, Inc.), Purchase Agreement (Sixth Street Lending Partners), Purchase Agreement (Sixth Street Lending Partners)

Disclosure Controls. The Company maintains disclosure controls and procedures (as such is defined in Rule 13a-15(e) of the Exchange Act Rules) that comply with the requirements of the Exchange Act; such disclosure controls and procedures have been designed to ensure that information required to be disclosed by the Company in reports that it files or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Commission’s rules and forms, including controls and procedures designed to ensure that such information is accumulated and communicated to the Company’s management to allow timely decisions regarding disclosures. The Company has conducted evaluations of the effectiveness of their its disclosure controls as required by Rule 13a-15 of the Exchange Act.

Appears in 18 contracts

Sources: Sales Agreement (Senseonics Holdings, Inc.), Underwriting Agreement (Senseonics Holdings, Inc.), Sales Agreement (G1 Therapeutics, Inc.)

Disclosure Controls. The Company maintains disclosure controls and procedures (as such is defined in Rule 13a-15(e) of the Exchange Act Rules) that comply with the requirements of the Exchange Act; such disclosure controls and procedures have been designed to ensure that information required to be disclosed by the Company in reports that it files or submit submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Commission’s rules and forms, including controls and procedures designed to ensure that such information is accumulated and communicated to the Company’s management to allow timely decisions regarding disclosures. The To the extent required by the Exchange Act Rules, the Company has conducted evaluations of the effectiveness of their its disclosure controls as required by Rule 13a-15 of the Exchange Act.

Appears in 16 contracts

Sources: Sales Agreement (Flux Power Holdings, Inc.), Sales Agreement (Cyclacel Pharmaceuticals, Inc.), Common Stock Sales Agreement (IsoRay, Inc.)

Disclosure Controls. The Company maintains an effective system of “disclosure controls and procedures procedures” (as such is defined in Rule 13a-15(e) of the Exchange Act RulesAct) that comply complies with the requirements of the Exchange Act; such disclosure controls Act and procedures have been that are designed to ensure that information required to be disclosed by the Company in reports that it files or submit submits under the Exchange Act is recorded, processed, summarized summarized, and reported within the time periods specified in the Commission’s rules and forms, including controls and procedures designed to ensure that such information is accumulated and communicated to the Company’s management as appropriate to allow timely decisions regarding disclosuresrequired disclosure. The Company has conducted evaluations carried out an evaluation of the effectiveness of their its disclosure controls and procedures as required by Rule 13a-15 of the Exchange Act.

Appears in 14 contracts

Sources: Underwriting Agreement (Blue Owl Capital Corp), Underwriting Agreement (Blue Owl Capital Corp), Equity Distribution Agreement (Blue Owl Capital Corp)

Disclosure Controls. The Company maintains disclosure controls and procedures (as such is defined in Rule 13a-15(e) of the Exchange Act Rules) that are designed to comply with the requirements of the Exchange Act; such disclosure controls and procedures have been designed to ensure that information required to be disclosed by the Company in reports that it files or submit submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Commission’s rules and forms, including controls and procedures designed to ensure that such information is accumulated and communicated to the Company’s management to allow timely decisions regarding disclosures. The Company has conducted evaluations of the effectiveness of their its disclosure controls as required by Rule 13a-15 of the Exchange Act.

Appears in 11 contracts

Sources: Sales Agreement (Brightcove Inc), Common Stock Sales Agreement (AppHarvest, Inc.), Sales Agreement (Romeo Power, Inc.)

Disclosure Controls. The Company maintains disclosure controls and procedures procedures” (as such is defined in Rule 13a-15(e) of the Exchange Act Rules) that comply with the requirements of the Exchange Act; such disclosure controls and procedures have been designed to ensure that information required to be disclosed by the Company in reports that it files or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Commission’s rules and forms, including controls and procedures designed to ensure that such information is accumulated and communicated to the Company’s management to allow timely decisions regarding disclosures. The Company has conducted evaluations of the effectiveness of their its disclosure controls as required by Rule 13a-15 of the Exchange Act.

Appears in 9 contracts

Sources: Underwriting Agreement (Monocle Acquisition Corp), Underwriting Agreement (Monocle Acquisition Corp), Underwriting Agreement (VectoIQ Acquisition Corp. II)

Disclosure Controls. The Company maintains and its subsidiaries maintain a system of “disclosure controls and procedures procedures” (as such is defined in Rule 13a-15(e) of the Exchange Act RulesAct) that comply complies with the requirements of the Exchange Act; such disclosure controls Act and procedures have has been designed to ensure that information required to be disclosed by the Company in reports that it files or submit submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Commission’s rules and forms, including controls and procedures designed to ensure that such information is accumulated and communicated to the Company’s management as appropriate to allow timely decisions regarding disclosuresrequired disclosure. The Company has conducted and its subsidiaries have carried out evaluations of the effectiveness of their disclosure controls and procedures as required by Rule 13a-15 of the Exchange Act.

Appears in 7 contracts

Sources: Underwriting Agreement (Clovis Oncology, Inc.), Underwriting Agreement (Clovis Oncology, Inc.), Underwriting Agreement (Clovis Oncology, Inc.)

Disclosure Controls. The Company maintains an effective system of “disclosure controls and procedures procedures” (as such is defined in Rule 13a-15(e) of the Exchange Act RulesAct) that comply complies with the requirements of the Exchange Act; such disclosure controls Act and procedures have that has been designed to ensure that information required to be disclosed by the Company in reports that it files or submit submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Commission’s rules and forms, including controls and procedures designed to ensure that such information is accumulated and communicated to the Company’s management as appropriate to allow timely decisions regarding disclosuresrequired disclosure. The Company Company’s management has conducted carried out evaluations of the effectiveness of their the Company’s disclosure controls and procedures as required by Rule 13a-15 of the Exchange Act.

Appears in 6 contracts

Sources: Underwriting Agreement (Oshkosh Corp), Underwriting Agreement (Oshkosh Corp), Purchase Agreement (Oshkosh Corp)

Disclosure Controls. The Company maintains disclosure controls and procedures (as such is defined in Rule 13a-15(e) 13a-15 and 15d-15 of the Exchange Act Rules) that comply with the requirements of the Exchange Act; such disclosure controls and procedures have been designed to ensure provide reasonable assurance that information required to be disclosed by the Company in reports that it files or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Commission’s rules and forms, including controls and procedures designed to ensure provide reasonable assurance that such information is accumulated and communicated to the Company’s management to allow timely decisions regarding disclosures. The Company has conducted evaluations of the effectiveness of their disclosure controls as required by Rule 13a-15 of the Exchange Act.

Appears in 5 contracts

Sources: Sales Agreement (Scynexis Inc), Sales Agreement (Scynexis Inc), Sales Agreement (Scynexis Inc)

Disclosure Controls. The Company maintains an effective system of “disclosure controls and procedures procedures” (as such is defined in Rule 13a-15(e) of the Exchange Act RulesAct) that has been designed to comply with the applicable requirements of the Exchange Act; such disclosure controls Act and procedures have been designed to ensure that information required to be disclosed by the Company in reports that it files or submit submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Commission’s rules and forms, including controls and procedures designed to ensure that such information is accumulated and communicated to the Company’s management as appropriate to allow timely decisions regarding disclosuresrequired disclosure. The Company has conducted evaluations carried out an evaluation of the effectiveness of their its disclosure controls and procedures as required by Rule 13a-15 of the Exchange Act.

Appears in 5 contracts

Sources: Underwriting Agreement (IDEAYA Biosciences, Inc.), Open Market Sales Agreement (IDEAYA Biosciences, Inc.), Underwriting Agreement (IDEAYA Biosciences, Inc.)

Disclosure Controls. The Company maintains an effective system of “disclosure controls and procedures procedures” (as such is defined in Rule 13a-15(e) of the Exchange Act RulesAct) that comply complies with the requirements of the Exchange Act; such disclosure controls Act and procedures have that has been designed to ensure that information required to be disclosed by the Company in reports that it files or submit submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Commission’s rules and forms, including controls and procedures designed to ensure that such information is accumulated and communicated to the Company’s management as appropriate to allow timely decisions regarding disclosuresrequired disclosure. The Company has conducted will carry out evaluations of the effectiveness of their its disclosure controls and procedures as required by Rule 13a-15 of the Exchange Act.

Appears in 4 contracts

Sources: Underwriting Agreement (Phreesia, Inc.), Underwriting Agreement (Phreesia, Inc.), Underwriting Agreement (Phreesia, Inc.)

Disclosure Controls. The Company maintains disclosure controls and procedures (as such is defined in Rule 13a-15(e) of the Exchange Act Rules) that comply with the requirements of the Exchange Act; such disclosure controls and procedures have been designed to ensure that information required to be disclosed by the Company in reports that it files or submit submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Commission’s rules and forms, including controls and procedures designed to ensure that such information is accumulated and communicated to the Company’s management to allow timely decisions regarding disclosures. The Company has conducted evaluations of the effectiveness of their disclosure controls as required by Rule 13a-15 of the Exchange Act.

Appears in 4 contracts

Sources: Underwriting Agreement (Syros Pharmaceuticals, Inc.), Underwriting Agreement (Syros Pharmaceuticals, Inc.), Underwriting Agreement (Syros Pharmaceuticals, Inc.)

Disclosure Controls. The Company maintains a system of “disclosure controls and procedures procedures” (as such is defined in Rule 13a-15(e) of the Exchange Act RulesAct) that comply complies with the requirements of the Exchange Act; such disclosure controls Act and procedures have that has been designed to ensure that information required to be disclosed by the Company in reports that it files or submit submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Commission’s rules and forms, including controls and procedures designed to ensure that such information is accumulated and communicated to the Company’s management as appropriate to allow timely decisions regarding disclosuresrequired disclosure. The Company has conducted carried out any evaluations of the effectiveness of their its disclosure controls and procedures as required by Rule 13a-15 of the Exchange Act.

Appears in 4 contracts

Sources: Common Shares Purchase Agreement (GT Biopharma, Inc.), Common Shares Purchase Agreement (NLS Pharmaceutics Ltd.), Common Stock Purchase Agreement (Delwinds Insurance Acquisition Corp.)

Disclosure Controls. The Company maintains disclosure controls and procedures (as such is defined in Rule 13a-15(e) of the Exchange Act Rules) that comply with the requirements of the Exchange Act; such disclosure controls and procedures have been designed to ensure that information required to be disclosed by the Company in reports that it files or submit submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Commission’s rules and forms, including controls and procedures designed to ensure that such information is accumulated and communicated to the Company’s management to allow timely decisions regarding disclosures. The Company has conducted evaluations of the effectiveness of their its disclosure controls as required by Rule 13a-15 of the Exchange Act.

Appears in 3 contracts

Sources: Sales Agreement (DermTech, Inc.), Sales Agreement (DermTech, Inc.), Underwriting Agreement (DermTech, Inc.)

Disclosure Controls. The Company maintains disclosure controls and procedures procedures” (as such is defined in Rule 13a-15(e) of the Exchange Act Rules) that comply with the requirements of the Exchange Act; such disclosure controls and procedures have been designed to ensure that information required to be disclosed by the Company in reports that it files or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Commission’s rules and forms, including controls and procedures designed to ensure that such information is accumulated and communicated to the Company’s management to allow timely decisions regarding disclosures. The Company has conducted evaluations of the effectiveness of their disclosure controls as required by Rule 13a-15 of the Exchange Act.

Appears in 3 contracts

Sources: Sales Agreement (Krystal Biotech, Inc.), Sales Agreement (Krystal Biotech, Inc.), Sales Agreement (Krystal Biotech, Inc.)

Disclosure Controls. The Company maintains disclosure controls and procedures (as such is defined in Rule 13a-15(e) of the Exchange Act Rules) that comply in all material respects with the requirements of the Exchange Act; such disclosure controls and procedures have been designed to ensure that information required to be disclosed by the Company in reports that it files or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Commission’s rules and forms, including controls and procedures designed to ensure that such information is accumulated and communicated to the Company’s management to allow timely decisions regarding disclosures. The Company has conducted evaluations of the effectiveness of their its disclosure controls as required by Rule 13a-15 of the Exchange Act.

Appears in 3 contracts

Sources: Common Stock Sales Agreement (Tonix Pharmaceuticals Holding Corp.), Common Stock Sales Agreement (Tonix Pharmaceuticals Holding Corp.), Sales Agreement (Tonix Pharmaceuticals Holding Corp.)

Disclosure Controls. The Company maintains disclosure controls and procedures (as such is defined in Rule 13a-15(e) of the Exchange Act Rules) that comply with the requirements of the Exchange Act; such disclosure controls and procedures have been designed to ensure provide reasonable assurance that information required to be disclosed by the Company in reports that it files or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Commission’s rules and forms, including controls and procedures designed to ensure provide reasonable assurance that such information is accumulated and communicated to the Company’s management to allow timely decisions regarding disclosures. The Company has conducted evaluations of the effectiveness of their disclosure controls as required by Rule 13a-15 of the Exchange Act.

Appears in 3 contracts

Sources: Sales Agreement (Scynexis Inc), Sales Agreement (Scynexis Inc), Sales Agreement (Scynexis Inc)

Disclosure Controls. The Company maintains disclosure controls and procedures (as such is defined in Rule 13a-15(e) of the Exchange Act Rules) that are designed to comply with the requirements of the Exchange Act; such disclosure controls and procedures have been designed to ensure that information required to be disclosed by the Company in reports that it files or submit submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Commission’s rules and forms, including controls and procedures designed to ensure that such information is accumulated and communicated to the Company’s management to allow timely decisions regarding disclosures. The Company has conducted evaluations of the effectiveness of their disclosure controls as required by Rule 13a-15 of the Exchange Act.

Appears in 3 contracts

Sources: Sales Agreement (Vericel Corp), Sales Agreement (Neos Therapeutics, Inc.), Sales Agreement (aTYR PHARMA INC)

Disclosure Controls. The Company maintains disclosure controls and procedures (as such is defined in Rule 13a-15(e) of the Exchange Act Rules) that comply with the requirements of the Exchange Act; such disclosure controls and procedures have been designed to ensure that information required to be disclosed by the Company in reports that it files or submit submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Commission’s rules and forms, including controls and procedures designed to ensure that such information is accumulated and communicated to the Company’s management to allow timely decisions regarding disclosures. The Company has conducted evaluations of the effectiveness of their disclosure controls as required by Rule 13a-15 of the Exchange Act.

Appears in 3 contracts

Sources: Sales Agreement (Merus N.V.), Sales Agreement (Immunogen Inc), Sales Agreement (Aclaris Therapeutics, Inc.)

Disclosure Controls. The Company maintains disclosure controls and procedures (as such is defined in Rule 13a-15(e) of the Exchange Act Rules) that comply with the requirements of the Exchange Act; such disclosure controls and procedures have been are reasonably designed to ensure that information required to be disclosed by the Company in reports that it files or submit submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Commission’s rules and forms, including controls and procedures designed to ensure that such information is accumulated and communicated to the Company’s management to allow timely decisions regarding disclosures. The Company has conducted evaluations of the effectiveness of their disclosure controls as required by Rule 13a-15 of the Exchange Act.

Appears in 3 contracts

Sources: Sales Agreement (Synlogic, Inc.), Sales Agreement (Synlogic, Inc.), Sales Agreement (Synlogic, Inc.)

Disclosure Controls. The Company maintains a system of “disclosure controls and procedures procedures” (as such is defined in Rule 13a-15(e) of the Exchange Act RulesAct) that comply complies with the requirements of the Exchange Act; such disclosure controls Act and procedures have that has been designed to ensure that information required to be disclosed by the Company in reports that it files or submit submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Commission’s rules and forms, including controls and procedures designed to ensure that such information is accumulated and communicated to the Company’s management as appropriate to allow timely decisions regarding disclosuresrequired disclosure. The Company has conducted carried out evaluations of the effectiveness of their its disclosure controls and procedures as required by Rule 13a-15 of the Exchange Act.

Appears in 2 contracts

Sources: Underwriting Agreement (Enel Chile S.A.), Underwriting Agreement (Belden Inc.)

Disclosure Controls. The Company maintains and its subsidiaries maintain an effective system of “disclosure controls and procedures procedures” (as such is defined in Rule 13a-15(e) of the Exchange Act RulesAct) that comply complies with the requirements of the Exchange Act; such disclosure controls Act and procedures have been is designed to ensure that information required to be disclosed by the Company in reports that it files or submit submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Commission’s rules and forms, including controls and procedures designed to ensure that such information is accumulated and communicated to the Company’s management as appropriate to allow timely decisions regarding disclosuresrequired disclosure. The Company has conducted and its subsidiaries have carried out evaluations of the effectiveness of their disclosure controls and procedures as required by Rule 13a-15 of the Exchange Act.

Appears in 2 contracts

Sources: Purchase Agreement (Brinker International, Inc), Underwriting Agreement (Brinker International, Inc)

Disclosure Controls. The Company maintains disclosure controls and procedures (as such term is defined in Rule 13a-15(e) of the Exchange Act Rules) that comply with the applicable requirements of the Exchange Act; such disclosure controls and procedures have been designed to ensure that information required to be disclosed by the Company in reports that it files or submit submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Commission’s rules and forms, including controls and procedures designed to ensure that such information is accumulated and communicated to the Company’s management to allow timely decisions regarding disclosures. The Company has conducted evaluations of the effectiveness of their disclosure controls as required by Rule 13a-15 of the Exchange Act.

Appears in 2 contracts

Sources: Underwriting Agreement (908 Devices Inc.), Underwriting Agreement (908 Devices Inc.)

Disclosure Controls. The Company maintains and its subsidiary maintain an effective system of “disclosure controls and procedures procedures” (as such is defined in Rule 13a-15(e) of the Exchange Act RulesAct) that comply complies with the requirements of the Exchange Act; such disclosure controls Act and procedures have that has been designed to ensure that information required to be disclosed by the Company in reports that it files or submit submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Commission’s rules and forms, including controls and procedures designed to ensure that such information is accumulated and communicated to the Company’s management as appropriate to allow timely decisions regarding disclosuresrequired disclosure. The Company has conducted carried out evaluations of the effectiveness of their its disclosure controls and procedures as required by Rule 13a-15 of the Exchange Act.

Appears in 2 contracts

Sources: Open Market Sale Agreement (Chimerix Inc), Common Stock Sales Agreement (Chimerix Inc)

Disclosure Controls. The Company maintains disclosure controls and procedures (as such term is defined in Rule 13a-15(e) of the Exchange Act Rules) that comply with the requirements of the Exchange Act; such disclosure controls and procedures have been designed to ensure that information required to be disclosed by the Company in reports that it files or submit submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Commission’s rules and forms, including controls and procedures designed to ensure that such information is accumulated and communicated to the Company’s management to allow timely decisions regarding disclosures. The Company has conducted evaluations of the effectiveness of their disclosure controls as required by Rule 13a-15 of the Exchange Act.

Appears in 2 contracts

Sources: Sales Agreement (AN2 Therapeutics, Inc.), Underwriting Agreement (AN2 Therapeutics, Inc.)

Disclosure Controls. The Company maintains an effective system of “disclosure controls and procedures procedures” (as such is defined in Rule 13a-15(e) of the Exchange Act RulesAct) that comply complies with the requirements of the Exchange Act; such disclosure controls Act and procedures have that has been designed to ensure that information required to be disclosed by the Company in reports that it files or submit submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Commission’s rules and forms, including controls and procedures designed to ensure that such information is accumulated and communicated to the Company’s management as appropriate to allow timely decisions regarding disclosuresrequired disclosure. The Company has conducted carried out evaluations of the effectiveness of their disclosure controls and procedures as required by Rule 13a-15 13a-15(b) of the Exchange Act.

Appears in 2 contracts

Sources: Underwriting Agreement (Strategic Hotels & Resorts, Inc), Underwriting Agreement (Strategic Hotels & Resorts, Inc)

Disclosure Controls. The Company maintains an effective system of “disclosure controls and procedures procedures” (as such is defined in Rule 13a-15(e) of the Exchange Act RulesAct) that comply complies with the requirements of the Exchange Act; such disclosure controls Act and procedures have that has been designed to ensure that information required to be disclosed by the Company in reports that it files or submit submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Commission’s rules and forms, including controls and procedures designed to ensure that such information is accumulated and communicated to the Company’s management as appropriate to allow timely decisions regarding disclosuresrequired disclosure. The Company has conducted carried out evaluations of the effectiveness of their its disclosure controls and procedures as required by Rule 13a-15 l3a-15 of the Exchange Act.

Appears in 2 contracts

Sources: Underwriting Agreement (Strategic Hotels & Resorts, Inc), Underwriting Agreement (Strategic Hotels & Resorts, Inc)

Disclosure Controls. The Company maintains disclosure controls and procedures (as such is defined in Rule 13a-15(e) of the Exchange Act Rules) that comply with the requirements of the Exchange Act; such disclosure controls and procedures have been reasonably designed to ensure that information required to be disclosed by the Company on a consolidated basis with its subsidiaries in reports that it files or submit submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Commission’s rules and forms, including controls and procedures designed to ensure that such information is accumulated and communicated to the Company’s management to allow timely decisions regarding disclosures. The Company has conducted evaluations of the effectiveness of their disclosure controls as required by Rule 13a-15 of the Exchange Act.

Appears in 2 contracts

Sources: Underwriting Agreement (Centogene N.V.), Underwriting Agreement (Centogene B.V.)

Disclosure Controls. The Company maintains disclosure controls and procedures (as such is defined in Rule 13a-15(e) of the Exchange Act Rules) that comply with the requirements of the Exchange Act; such disclosure controls and procedures have been designed to ensure that information required to be disclosed by the Company in reports that it files or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Commission’s rules and forms, including controls and procedures designed to ensure that such information is accumulated and communicated to the Company’s management to allow timely decisions regarding disclosures. The To the extent required by the Exchange Act Rules, the Company has conducted evaluations of the effectiveness of their its disclosure controls as required by Rule 13a-15 of the Exchange Act.

Appears in 2 contracts

Sources: Sales Agreement (Aduro Biotech, Inc.), Common Stock Sales Agreement (Aduro Biotech, Inc.)

Disclosure Controls. The Company maintains disclosure controls and procedures (as such term is defined in Rule 13a-15(e) of the Exchange Act Rules) that comply with the requirements of the Exchange Act; such disclosure controls and procedures have been designed to ensure that information required to be disclosed by the Company in reports that it files or submit submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Commission’s rules and forms, including controls and procedures designed to ensure that such information is accumulated and communicated to the Company’s management to allow timely decisions regarding disclosures. The Company has conducted evaluations of the effectiveness of their its disclosure controls as required by Rule 13a-15 of the Exchange Act.

Appears in 2 contracts

Sources: Sales Agreement (Syndax Pharmaceuticals Inc), Sales Agreement (Madrigal Pharmaceuticals, Inc.)

Disclosure Controls. The Company maintains disclosure controls and procedures (as such is defined in Rule 13a-15(e) of the Exchange Act Rules) that comply with the requirements of the Exchange Act; such disclosure controls and procedures have been designed to ensure that information required to be disclosed by the Company in reports that it files or submit submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Commission’s rules and forms, including controls and procedures designed to ensure that such information is accumulated and communicated to the Company’s management to allow timely decisions regarding disclosures. The Company has conducted evaluations of the effectiveness of their disclosure controls as required by Rule 13a-15 of the Exchange Act.

Appears in 2 contracts

Sources: Underwriting Agreement (Viewray Inc), Underwriting Agreement (Viewray Inc)

Disclosure Controls. The Company maintains disclosure controls and procedures (as such term is defined in Rule 13a-15(e) of the Exchange Act Rules) that comply with the requirements of the Exchange Act; such disclosure controls and procedures have been designed to ensure that information required to be disclosed by the Company in reports that it files or submit submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Commission’s rules and forms, including controls and procedures designed to ensure that such information is accumulated and communicated to the Company’s management to allow timely decisions regarding disclosures. The Company has conducted evaluations of the effectiveness of their disclosure controls as required by Rule 13a-15 of the Exchange Act.

Appears in 2 contracts

Sources: Sales Agreement (Madrigal Pharmaceuticals, Inc.), Sales Agreement (Madrigal Pharmaceuticals, Inc.)

Disclosure Controls. The Company maintains an effective system of “disclosure controls and procedures procedures” (as such is defined in Rule 13a-15(e) of under the Exchange Act Rules▇▇▇▇ ▇▇▇) that comply with the requirements of the Exchange Act; such disclosure controls and procedures have been is designed to ensure that information relating to the Company and its consolidated subsidiaries and required to be disclosed by the Company in reports that it files or submit submits under the Exchange 1934 Act is recorded, processed, summarized and reported within the time periods specified in the Commission’s rules and forms, including controls and procedures designed to ensure that such information is accumulated and communicated to the Company’s management as appropriate to allow timely decisions regarding disclosuresrequired disclosure. The Company has conducted carried out evaluations of the effectiveness of their its disclosure controls and procedures as required by Rule 13a-15 of 13a-15(e) under the Exchange 1934 Act.

Appears in 1 contract

Sources: Underwriting Agreement (CubeSmart, L.P.)

Disclosure Controls. The Company maintains disclosure controls and procedures (as such is defined in Rule 13a-15(e) of the Exchange Act Rules) that are designed to comply with the requirements of the Exchange Act; such disclosure controls and procedures have been designed to ensure that information required to be disclosed by the Company in reports that it files or submit submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Commission’s 's rules and forms, including controls and procedures designed to ensure that such information is accumulated and communicated to the Company’s 's management to allow timely decisions regarding disclosures. The Company has conducted evaluations of the effectiveness of their disclosure controls as required by Rule 13a-15 of the Exchange Act.

Appears in 1 contract

Sources: Common Stock Sales Agreement (Opgen Inc)

Disclosure Controls. The Company maintains an effective system of “disclosure controls and procedures procedures” (as such is defined in Rule 13a-15(e) of the Exchange Act RulesAct) that comply complies with the requirements of the Exchange Act; such disclosure controls Act and procedures have that has been designed to ensure that information required to be disclosed by the Company in reports that it files or submit submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Commission’s rules and forms, including controls and procedures designed to ensure that such information is accumulated and communicated to the Company’s management as appropriate to allow timely decisions regarding disclosuresrequired disclosure. The Company has conducted have carried out evaluations of the effectiveness of their disclosure controls and procedures as required by Rule 13a-15 of the Exchange Act.

Appears in 1 contract

Sources: Underwriting Agreement (Clearside Biomedical, Inc.)

Disclosure Controls. The Company maintains maintain disclosure controls and procedures (as such is defined in Rule 13a-15(e) of the Exchange Act Rules) that comply with the requirements of the Exchange Act; such disclosure controls and procedures have been designed to ensure that information required to be disclosed by the Company in reports that it files or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Commission’s rules and forms, including controls and procedures designed to ensure that such information is accumulated and communicated to the Company’s management to allow timely decisions regarding disclosures. The Company has conducted evaluations of the effectiveness of their its disclosure controls as required by Rule 13a-15 of the Exchange Act.

Appears in 1 contract

Sources: Sales Agreement (Senseonics Holdings, Inc.)

Disclosure Controls. The Company maintains disclosure controls and procedures (as such term is defined in Rule 13a-15(e) of the Exchange Act Rules) that comply with the requirements of the Exchange Act; such disclosure controls and procedures have been designed to ensure that information required to be disclosed by the Company in reports that it files or submit submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Commission’s rules and forms, including controls and procedures designed to ensure that such information is accumulated and communicated to the Company’s management to allow timely decisions regarding disclosures. The Company has conducted carried out evaluations of the effectiveness of their its disclosure controls and procedures as required by Rule 13a-15 of the Exchange Act.

Appears in 1 contract

Sources: Underwriting Agreement (AN2 Therapeutics, Inc.)

Disclosure Controls. The Company maintains disclosure controls and procedures (as such is defined in Rule 13a-15(e) of the Exchange Act Rules) that comply with the requirements of the Exchange Act; such disclosure controls and procedures have been designed to ensure that information required to be disclosed by the Company in reports that it files or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Commission’s rules and forms, including controls and procedures designed to ensure that such information is accumulated and communicated to the Company’s management to allow timely decisions regarding disclosures. The Company has conducted 122817078 v5 evaluations of the effectiveness of their its disclosure controls as required by Rule 13a-15 of the Exchange Act.

Appears in 1 contract

Sources: Sales Agreement (Threshold Pharmaceuticals Inc)

Disclosure Controls. The Company maintains an effective system of “disclosure controls and procedures procedures” (as such is defined in Rule 13a-15(e) of the Exchange Act RulesAct) that comply with the requirements of the Exchange Act; such disclosure controls and procedures have been is designed to ensure that material information required to be disclosed by the Company Company, including its consolidated subsidiaries, in reports that it files or submit submits under the Exchange Act is recorded, processed, summarized and reported as required under the Exchange Act within the time periods specified in the CommissionSEC’s rules and forms, including controls and procedures designed to ensure that such information is accumulated and communicated to the Company’s management as appropriate to allow timely decisions regarding disclosuresrequired disclosure. The Company has conducted carried out evaluations of the effectiveness of their its disclosure controls and procedures as required by Rule 13a-15 of the Exchange Act.

Appears in 1 contract

Sources: Purchase Agreement (Exco Resources Inc)

Disclosure Controls. The Company maintains an effective system of “disclosure controls and procedures procedures” (as such is defined in Rule 13a-15(e) of the Exchange Act RulesAct) that comply complies with the requirements of the Exchange Act; such disclosure controls Act and procedures have that has been designed to ensure that material information required to be disclosed by the Company in reports that it files or submit submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Commission’s rules and forms, including controls and procedures designed to ensure that such information is accumulated and communicated to the Company’s management as appropriate to allow timely decisions regarding disclosuresrequired disclosure. The Company has conducted carried out evaluations of the effectiveness of their its disclosure controls and procedures as required by Rule 13a-15 of the Exchange Act.. (dd)

Appears in 1 contract

Sources: Underwriting Agreement (Columbus McKinnon Corp)

Disclosure Controls. The Company maintains disclosure controls and procedures (as such is defined in Rule 13a-15(e) of the Exchange Act Rules) that comply with the requirements of the Exchange Act; such disclosure controls and procedures have been designed to ensure provide reasonable assurances that information required to be disclosed by the Company in reports that it files they file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Commission’s rules and forms, including controls and procedures designed to ensure that such information is accumulated and communicated to the Company’s management to allow timely decisions regarding disclosures. The Company has conducted evaluations of the effectiveness of their disclosure controls as required by Rule 13a-15 of the Exchange Act.

Appears in 1 contract

Sources: Underwriting Agreement (Nivalis Therapeutics, Inc.)

Disclosure Controls. The Company maintains disclosure controls and procedures (as such term is defined in Rule 13a-15(e) of the Exchange Act Rules) that reasonably designed to comply with the requirements of the Exchange Act; such disclosure controls and procedures have been reasonably designed to ensure that information required to be disclosed by the Company in reports that it files or submit submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Commission’s rules and forms, including controls and procedures designed to ensure that such information is accumulated and communicated to the Company’s management to allow timely decisions regarding disclosures. The Company has conducted evaluations of the effectiveness of their disclosure controls as required by Rule 13a-15 of the Exchange Act.

Appears in 1 contract

Sources: Underwriting Agreement (Nkarta, Inc.)

Disclosure Controls. The Company maintains disclosure controls and procedures (as such is defined in Rule 13a-15(e) of the Exchange Act Rules) that comply with the requirements of the Exchange Act; such disclosure controls and procedures have been designed to ensure that information required to be disclosed by the Company in reports that it files or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Commission’s rules and forms, including controls and procedures designed to ensure that such information is accumulated and communicated to the Company’s management to allow timely decisions regarding disclosures. The Company has conducted evaluations of the effectiveness of their disclosure controls as required by Rule 13a-15 of the Exchange Act.

Appears in 1 contract

Sources: Sales Agreement (Greenlane Holdings, Inc.)

Disclosure Controls. The Company maintains disclosure controls and procedures (as such is defined in Rule 13a-15(e) of the Exchange Act Rules) that comply with the requirements of the Exchange Act; such disclosure controls and procedures have been designed to ensure that information required to be disclosed by the Company and its subsidiaries in reports that it files they file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Commission’s rules and forms, including controls and procedures designed to ensure that such information is accumulated and communicated to the Company’s management to allow timely decisions regarding disclosures. The Company has conducted evaluations of the effectiveness of their its disclosure controls as required by Rule 13a-15 of the Exchange Act.

Appears in 1 contract

Sources: Underwriting Agreement (Bavarian Nordic a/S / ADR)

Disclosure Controls. The Company maintains disclosure controls and procedures (as such is defined in Rule 13a-15(e) of the Exchange Act Rules) that comply with the requirements of the Exchange Act; such disclosure controls and procedures have been designed to ensure that material information required to be disclosed by the Company in reports that it files or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Commission’s rules and forms, including controls and procedures designed to ensure that such information is accumulated and communicated to the Company’s management to allow timely decisions regarding disclosures. The Company has conducted evaluations of the effectiveness of their its disclosure controls as required by Rule 13a-15 of the Exchange ActAct Rules.

Appears in 1 contract

Sources: Sales Agreement (TerraVia Holdings, Inc.)

Disclosure Controls. The Company maintains and its subsidiaries maintain a system of "disclosure controls and procedures procedures" (as such is defined in Rule 13a-15(e) of the Exchange Act RulesAct) that comply complies with the requirements of the Exchange Act; such disclosure controls Act and procedures have has been designed to ensure that information required to be disclosed by the Company in reports that it files or submit submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Commission’s 's rules and forms, including controls and procedures designed to ensure that such information is accumulated and communicated to the Company’s 's management as appropriate to allow timely decisions regarding disclosuresrequired disclosure. The Company has conducted and its subsidiaries have carried out evaluations of the effectiveness of their disclosure controls and procedures as required by Rule 13a-15 of the Exchange Act.

Appears in 1 contract

Sources: Underwriting Agreement (Unifirst Corp)

Disclosure Controls. The Company maintains an effective system of “disclosure controls and procedures procedures” (as such is defined in Rule 13a-15(e) of the Securities Exchange Act Rulesof 1934, as amended (the “Exchange Act”)) that comply with the requirements of the Exchange Act; such disclosure controls and procedures have been are designed to ensure that information required to be disclosed by the Company in reports that it files or submit submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Commission’s rules and forms, including controls and procedures designed to ensure that such information is accumulated and communicated to the Company’s management as appropriate to allow timely decisions regarding disclosuresrequired disclosure. The Company has conducted evaluations carried out an evaluation of the effectiveness of their its disclosure controls and procedures as required by Rule 13a-15 of the Exchange Act.

Appears in 1 contract

Sources: Underwriting Agreement (Owl Rock Capital Corp)

Disclosure Controls. The Company maintains disclosure controls and procedures (as such is defined in Rule 13a-15(e) of the Exchange Act Rules) that comply with the requirements of the Exchange Act; such disclosure controls and procedures have been designed to ensure that information required to be disclosed by the Company in reports that it files or submit submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Commission’s rules and forms, including controls and procedures designed to ensure that such information is accumulated and communicated to the Company’s management to allow timely decisions regarding disclosures. The Company has conducted evaluations of the effectiveness of their its disclosure controls as required by Rule 13a-15 of the Exchange Act.. (dd)

Appears in 1 contract

Sources: Common Stock Sales Agreement (NUSCALE POWER Corp)

Disclosure Controls. The Company maintains an effective system of “disclosure controls and procedures procedures” (as such is defined in Rule 13a-15(e) of the Exchange Act RulesAct) that comply complies with the requirements of the Exchange Act; such disclosure controls Act and procedures have that has been designed to ensure that material information required to be disclosed by the Company in reports that it files or submit submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Commission’s rules and forms, including controls and procedures designed to ensure that such information is accumulated and communicated to the Company’s management as appropriate to allow timely decisions regarding disclosuresrequired disclosure. The Company has conducted carried out evaluations of the effectiveness of their its disclosure controls and procedures as required by Rule 13a-15 of the Exchange Act.

Appears in 1 contract

Sources: Underwriting Agreement (Columbus McKinnon Corp)

Disclosure Controls. The Company maintains disclosure controls and procedures (as such is defined in Rule 13a-15(e13a‑15(e) of the Exchange Act Rules) that are designed to comply with the requirements of the Exchange Act; such disclosure controls and procedures have been designed to ensure that information required to be disclosed by the Company in reports that it files or submit submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Commission’s rules and forms, including controls and procedures designed to ensure that such information is accumulated and communicated to the Company’s management to allow timely decisions regarding disclosures. The Company has conducted evaluations of the effectiveness of their disclosure controls as required by Rule 13a-15 13a‑15 of the Exchange Act.

Appears in 1 contract

Sources: Sales Agreement (Rocket Pharmaceuticals, Inc.)

Disclosure Controls. The Company maintains an effective system of “disclosure controls and procedures procedures” (as such is defined in Rule 13a-15(e) of the Exchange Act Rules1934 Act) that comply complies with the requirements of the Exchange Act; such disclosure controls 1934 Act and procedures have that has been designed to ensure that information required to be disclosed by the Company in reports that it files or submit submits under the Exchange 1934 Act is recorded, processed, summarized and reported within the time periods specified in the Commission’s rules and forms, including controls and procedures designed to ensure that such information is accumulated and communicated to the Company’s management as appropriate to allow timely decisions regarding disclosuresrequired disclosure. The Company has conducted carried out evaluations of the effectiveness of their its disclosure controls and procedures as required by Rule 13a-15 of the Exchange 1934 Act.

Appears in 1 contract

Sources: Underwriting Agreement (Fate Therapeutics Inc)

Disclosure Controls. The Company maintains disclosure controls and procedures (as such is defined in Rule 13a-15(e) of the Exchange Act Rules) that reasonably designed to comply with the requirements of the Exchange Act; such disclosure controls and procedures have been reasonably designed to ensure that information required to be disclosed by the Company in reports that it files or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Commission’s rules and forms, including controls and procedures designed to ensure that such information is accumulated and communicated to the Company’s management to allow timely decisions regarding disclosures. The Company has conducted evaluations of the effectiveness of their disclosure controls as required by Rule 13a-15 of the Exchange Act.

Appears in 1 contract

Sources: Sales Agreement (Nkarta, Inc.)

Disclosure Controls. The Company maintains disclosure controls and procedures (as such term is defined in Rule 13a-15(e) of the Exchange Act RulesAct) that comply with the requirements of the Exchange Act; such disclosure controls and procedures have been designed to ensure that information required to be disclosed by the Company in reports that it files or submit submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Commission’s rules and forms, including controls and procedures designed to ensure that such information is accumulated and communicated to the Company’s management to allow timely decisions regarding disclosures. The Company has conducted evaluations of the effectiveness of their disclosure controls as required by Rule 13a-15 of the Exchange Act.

Appears in 1 contract

Sources: Sales Agreement (Pieris Pharmaceuticals, Inc.)

Disclosure Controls. The Company maintains disclosure controls and procedures (as such is defined in Rule 13a-15(e) of the Exchange Act Rules) that designed to comply with the requirements of the Exchange Act; such disclosure controls and procedures have been designed to ensure that information regarding the Company and its subsidiaries required to be disclosed by the Company in reports that it files or submit submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Commission’s rules and forms, including controls and procedures designed to ensure that such information is accumulated and communicated to the Company’s management to allow timely decisions regarding disclosures. The Company has conducted evaluations of the effectiveness of their its disclosure controls as required by Rule 13a-15 of the Exchange Act.

Appears in 1 contract

Sources: Underwriting Agreement (Clearfield, Inc.)

Disclosure Controls. The Company maintains disclosure controls and procedures (as such term is defined in Rule 13a-15(e) of the Exchange Act RulesAct) that comply with the requirements of the Exchange Act; such disclosure controls and procedures have been designed to ensure that information required to be disclosed by the Company in reports that it files or submit submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Commission’s rules and forms, including controls and procedures designed to ensure that such information is accumulated and communicated to the Company’s management to allow timely decisions regarding disclosures. The Company has conducted evaluations of the effectiveness of their its disclosure controls as required by Rule 13a-15 of the Exchange Act.

Appears in 1 contract

Sources: Sales Agreement (Corindus Vascular Robotics, Inc.)

Disclosure Controls. The Company maintains disclosure controls and procedures (as such is defined in Rule 13a-15(e) of under the Exchange Act RulesAct) that comply with the requirements of the Exchange Act; such disclosure controls and procedures have been designed to ensure that information required to be disclosed by the Company in reports that it files or submit submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Commission’s rules and forms, including controls and procedures designed to ensure that such information is accumulated and communicated to the Company’s management to allow timely decisions regarding disclosures. The Company has conducted evaluations of the effectiveness of their disclosure controls as required by Rule 13a-15 of the Exchange Act.

Appears in 1 contract

Sources: Shares of Common Stock Sales Agreement (Xilio Therapeutics, Inc.)

Disclosure Controls. The Company maintains disclosure controls and procedures (as such is defined in Rule 13a-15(e) of the Exchange Act Rules) that reasonably designed to comply with the requirements of the Exchange Act; such disclosure controls and procedures have been designed to ensure that information required to be disclosed by the Company in reports that it files or submit submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Commission’s rules and forms, including controls and procedures designed to ensure that such information is accumulated and communicated to the Company’s management to allow timely decisions regarding disclosures. The Company has conducted evaluations of the effectiveness of their disclosure controls as required by Rule 13a-15 of the Exchange Act.

Appears in 1 contract

Sources: Underwriting Agreement (Spruce Biosciences, Inc.)

Disclosure Controls. The Company maintains has established an effective system of “disclosure controls and procedures procedures” (as such is defined in Rule 13a-15(e) of the Exchange Act RulesAct) that comply complies with the requirements of the Exchange Act; such disclosure controls Act and procedures have that has been designed to ensure that information required to be disclosed by the Company in reports that it files or submit submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Commission’s rules and forms, including controls and procedures designed to ensure that such information is accumulated and communicated to the Company’s management as appropriate to allow timely decisions regarding disclosuresrequired disclosure. The Company has conducted carried out evaluations of the effectiveness of their disclosure controls and procedures as required by Rule 13a-15 of the Exchange Act.

Appears in 1 contract

Sources: Underwriting Agreement (Spark Therapeutics, Inc.)

Disclosure Controls. The Company maintains an effective system of “disclosure controls and procedures procedures” (as such is defined in Rule 13a-15(e) of the Exchange Act Rules) that comply with the requirements of under the Exchange Act; such disclosure controls and procedures have been ) that is designed to ensure that information relating to the Company and its consolidated.subsidiaries and required to be disclosed by the Company in reports that it files or submit submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Commission’s rules and forms, including controls and procedures designed to ensure that such information is accumulated and communicated to the Company’s management as appropriate to allow timely decisions regarding disclosuresrequired disclosure. The Company has conducted carried out evaluations of the effectiveness of their its disclosure controls and procedures as required by Rule 13a-15 of 13a-15(e) under the Exchange Act.

Appears in 1 contract

Sources: Underwriting Agreement (U-Store-It Trust)

Disclosure Controls. The Company maintains disclosure controls and procedures (as such is defined in Rule 13a-15(e) of the Exchange Act Rules) that comply with the requirements of the Exchange ActAct in all material respects; such disclosure controls and procedures have been designed to ensure that information required to be disclosed by the Company in reports that it files or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Commission’s rules and forms, including controls and procedures designed to ensure that such information is accumulated and communicated to the Company’s management to allow timely decisions regarding disclosures. The Company has conducted evaluations of the effectiveness of their disclosure controls as required by Rule 13a-15 of the Exchange Act.

Appears in 1 contract

Sources: Sales Agreement (22nd Century Group, Inc.)

Disclosure Controls. The Company maintains disclosure controls and procedures (as such is defined in Rule 13a-15(e) of the Exchange Act Rules) that comply in all material respects with the requirements of the Exchange Act; such disclosure controls and procedures have been designed to ensure that information required to be disclosed by the Company in reports that it files or submit submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Commission’s rules and forms, including controls and procedures designed to ensure that such information is accumulated and communicated to the Company’s management to allow timely decisions regarding disclosures. The Company has conducted evaluations of the effectiveness of their its disclosure controls as required by Rule 13a-15 of the Exchange Act.

Appears in 1 contract

Sources: Sales Agreement (GeneDx Holdings Corp.)

Disclosure Controls. The Company maintains an effective system of “disclosure controls and procedures procedures” (as such is defined in Rule 13a-15(e) of the Exchange Act Rules1934 Act) that comply complies with the requirements of the Exchange Act; such disclosure controls 1934 Act and procedures have that has been designed to ensure that information required to be disclosed by the Company in reports that it files or submit submits under the Exchange 1934 Act is recorded, processed, summarized and reported within the time periods specified in the Commission’s rules and forms, including controls and procedures designed to ensure that such information is accumulated and communicated to the Company’s management as appropriate to allow timely decisions regarding disclosuresrequired disclosure. The Company has conducted evaluations carried out an evaluation of the effectiveness of their its disclosure controls and procedures as required by Rule 13a-15 of the Exchange 1934 Act.

Appears in 1 contract

Sources: Equity Distribution Agreement (Sixth Street Specialty Lending, Inc.)

Disclosure Controls. The Company maintains an effective system of “disclosure controls and procedures procedures” (as such is defined in Rule 13a-15(e) of the Exchange Act RulesAct) that comply complies with the requirements of the Exchange Act; such disclosure controls Act and procedures have that has been designed to ensure that information required to be disclosed by the Company in reports that it files or submit submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Commission’s rules and forms, including controls and procedures designed to ensure that such information is accumulated and communicated to the Company’s management as appropriate to allow timely decisions regarding disclosuresrequired disclosure. The Company has conducted carried out evaluations of the effectiveness of their its disclosure controls and procedures as required by Rule 13a-15 of the Exchange ActAct through December 31, 2023.

Appears in 1 contract

Sources: Underwriting Agreement (Precision Biosciences Inc)

Disclosure Controls. The Company maintains disclosure controls and procedures (as such is defined in Rule 13a-15(e) of the Exchange Act Rules) that comply with the requirements of the Exchange Act; such disclosure controls and procedures have been designed to ensure that information required to be disclosed by the Company in reports that it files or submit submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Commission’s 's rules and forms, including controls and procedures designed to ensure that such information is accumulated and communicated to the Company’s 's management to allow timely decisions regarding disclosures. The To the extent required by the Exchange Act Rules, the Company has conducted evaluations of the effectiveness of their its disclosure controls as required by Rule 13a-15 of the Exchange Act.

Appears in 1 contract

Sources: Sales Agreement (Innovate Biopharmaceuticals, Inc.)

Disclosure Controls. The Company maintains disclosure controls and procedures (as such term is defined in Rule 13a-15(e) of the Exchange Act Rules) that reasonably designed to comply with the requirements of the Exchange Act; such disclosure controls and procedures have been reasonably designed to ensure that information required to be disclosed by the Company in reports that it files or submit submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Commission’s rules and forms, including controls and procedures designed to ensure that such information is accumulated and communicated to the Company’s management to allow timely decisions regarding disclosures. The Company has conducted evaluations of the effectiveness of their disclosure controls as required by Rule 13a-15 of the Exchange Act.. (mm)

Appears in 1 contract

Sources: Underwriting Agreement (Nkarta, Inc.)